Skip to main content
. 2013 May 23;8(9):1515–1523. doi: 10.2215/CJN.10491012

Table 5.

Indications for performing LMD/MS for typing of renal amyloidosis

Lack of tissue for immunofluorescence
Negative immunofluorescence staining for κ and λ, and negative immunohistochemistry staining for SAA
Equal immunofluorescence staining for κ and λ
Strong immunofluorescence staining for ≥ Ig heavy chain (with or without staining for Ig light chains)
Positive immunofluorescence staining for IgG, IgA, κ, and/or λ, with positive immunohistochemistry staining for SAA
Equivocal Congo red stain

LMD/MS, laser microdissection/mass spectrometry; SAA, serum amyloid A.